Skip to content

The Efficacy of Familiar Voice Stimulation During Coma Recovery

Can Neural Adaptation After Severe Brain Injury be Facilitated?

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00557076
Acronym
FAST
Enrollment
21
Registered
2007-11-12
Start date
2008-07-31
Completion date
2012-09-30
Last updated
2019-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coma, Minimally Conscious State, Traumatic Brain Injury, Vegetative State

Keywords

Randomized Clinical Trial, Auditory Stimulation

Brief summary

The purpose of the study is to determine whether familiar vocal stimulation, provided during coma recovery, improves outcomes for persons who are unconscious after severe TBI. The primary hypothesis is that unconscious persons who receive standard rehabilitation (SR) plus a high-dose of Familiar Voice stimulation (FVs) compared to unconscious persons who receive SR plus a sham stimulation (Sham Group) will demonstrate: 1. Significantly more neurobehavioral functioning post-intervention compared to pre-intervention. 2. Using Functional Magnetic Resonance Imaging (fMRI), significantly higher average measures of volumetric activity in the whole brain, middle temporal gyrus bilaterally, primary auditory area, bilateral pre-frontal cortex, hippocampus and/or the cerebellum post-intervention compared to pre-intervention.

Detailed description

Medical advances have improved the odds of surviving a severe traumatic brain injury (TBI) thereby increasing demands for rehabilitation. Medical rehabilitation management during coma recovery, however, has been hampered by a paucity of rigorous clinical trials examining rehabilitation effectiveness. This randomized clinical trial addresses this knowledge gap. The purpose of the study is to determine whether a high dose of familiar vocal stimulation (FVs) improves outcomes for persons who are unconscious after severe TBI. The research objectives are to: 1. Determine whether neural responses elicited with FVs improve neurobehavioral outcomes and/or elicit activations in expected regions. 2. Examine the relationship between neurobehavioral and neurophysiological responses to high doses of FVs during coma recovery. There are two study cohorts and each group receives standard rehabilitation. The experimental group will be exposed daily to 40 minutes of FVs for 6 weeks. The Sham Group (Control Group 2) will receive 40 minutes of sham treatment, or silence, daily for 6 weeks. The 40 minutes of FVs treatment will be provided in four 10 minute sessions. Each FV session will start with the subject hearing a familiar voice call the 'Subject's Own Name' aloud and then that same voice re-telling a memory or an event familiar to the subject. The person re-telling the event will be a person who experienced the event with the subject and who interacted with the subject on a daily basis for at least 1 year prior to injury.

Interventions

BEHAVIORALFamiliar Auditory Sensory Training

Patient is provided with customized recordings of stories told by people well known to the patient at least 1 year prior to injury. The stories represent specific events experienced by both the patient and the storyteller. Patients received FAST for 10 minutes 4 times per day, with at least 2 hours in between, for 6 week.

BEHAVIORALSham Auditory Sensory Training

The sham intervention is zero minutes of Familiar Auditory Sensory Training. Each day for 6 weeks 0 minutes of Familiar voice stimulation will be provided in 10 minute daily segments for 6 weeks. Each 10 minute recording is a digital recording of silence.

Sponsors

Shirley Ryan AbilityLab
CollaboratorOTHER
Northwestern Memorial Hospital
CollaboratorOTHER
Northwestern University Feinberg School of Medicine
CollaboratorOTHER
VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Severe brain injury of traumatic origin * Non-brain penetrating gun shot wound * Blunt trauma with subsequent closed head injuries such as diffuse axonal injury * 18 years of age or older * Unconscious for at least 28 days consecutively * Medically Stable * Does not have active seizures

Exclusion criteria

* History of brain injury * More than 1 year post injury * MRI is contraindicated (e.g., metal, titanium in brain) * Ventilator dependent * Cardiac contraindications * The definition of traumatic brain injury excludes: (a) Lacerations or contusions of the face, eye, ear or scalp and fractures of facial bones with-out loss of consciousness; (b) Primary cause of injury is blunt trauma (e.g., contusion from blow to head) without subsequent closed head injuries such as contra coup or diffuse axonal injury; (c) Brain-penetrating gun shot wound; (d) Primary BI due to anoxic, inflammatory, infectious, toxic metabolic encephalopathies; (e) Cancer, brain infarction (ischemic stroke), intracranial hemorrhage (hemorrhagic stroke) aneurysms and arterio-venous malformations.

Design outcomes

Primary

MeasureTime frameDescription
DOCS Neurobehavioral Measure (DOCS = Disorders of Consciousness Scale) ChangeBaseline and immediately after treatment ends (6 weeks after Baseline)The primary outcome, the DOCS, is a reliable, valid and precise measure of global neurobehavioral functioning shown to remain stable over six weeks.The DOCS-25 starts with a systematic observation followed by administration of 25 sensory stimuli. Best responses to each stimulus are rated on a scale of 0 to 2 and total raw scores range from 0 (worst) to 50 (best). The DOCS change was calculated as the value at endpoint (6 weeks after Baseline) minus the value at Baseline.

Secondary

MeasureTime frameDescription
Coma Near Coma ScaleBaseline and after the 8th CNC assessment (4 weeks after Baseline)The CNC scale measures arousal and awareness and test stimuli are administered to elicit a specified behavior. Presence/absence of this behavior is scored as 0, 2 or 4. Total raw scores range from 0 (consistently responsive) to 36 (extreme coma). The CNC change score was calculated as the 8th CNC measure minus the Baseline CNC measure. Since 2 CNC measurements were collected per week, the 8th CNC measure occurred in Week 4. To calculate the change, we used the eighth CNC measure because two patients (one per group) recovered full consciousness after the eighth CNC measure. In the second statistical analysis, all CNC measures were used to calculate the slope; this includes the Baseline CNC and CNC measures 2-8. Again, we used the first 8 CNC measures (instead of all 12 collected over 6 weeks of treatment) because two patients recovered full consciousness after the eighth CNC measure.

Countries

United States

Participant flow

Recruitment details

Subjects were recruited from a large urban community population and two acute rehabilitation hospitals. Community participants included patients not treated at the two acute rehabilitation hospitals. Acute rehabilitation programs included one U.S.

Pre-assignment details

All patients with possible impairment in sound conduction were withdrawn prior to randomization. In total, 5 participants were withdrawn prior to randomization: 1 participant failed the auditory pathway screen, 2 participants recovered full consciousness, and 2 participants were placed in hospice by LAR. Therefore 16 participants were randomized.

Participants by arm

ArmCount
FAST
high dose of familiar voice stimulation Familiar Voice Stimulation High Dose: The High Dose intervention is 1,680 minutes of Familiar Vocal Stimulation (FVs) provided in 40 minute daily segments at least 2 hours apart and for 6 weeks. Four CDs with 10 minutes of FVs preceded by the familiar voice calling out the subject's name, will be played (1 at a time) each day for 6 weeks providing 1,680 minutes of FVs.
8
Sham
sham auditory stimulation Sham Auditory Stimulation: The sham intervention is zero minutes of Familiar Voice Stimulation. Each day for 6 weeks 0 minutes of Familiar voice stimulation will be provided in 10 minute daily segments for 6 weeks. Each 10 minute recording is a digital recording of silence.
7
Total15

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyUnblinding01

Baseline characteristics

CharacteristicFASTTotalSham
Age, Continuous35.6 years
STANDARD_DEVIATION 11
35.1 years
STANDARD_DEVIATION 11
34.4 years
STANDARD_DEVIATION 12
Education Achieved at Injury
Bachelor Degree
2 participants4 participants2 participants
Education Achieved at Injury
Graduate or Professional Degree
1 participants2 participants1 participants
Education Achieved at Injury
High School Graduate or GED
4 participants5 participants1 participants
Education Achieved at Injury
Some College, No Degree
1 participants4 participants3 participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants3 Participants1 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
6 Participants12 Participants6 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
1 Participants2 Participants1 Participants
Race (NIH/OMB)
Black or African American
2 Participants3 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants0 Participants0 Participants
Race (NIH/OMB)
White
5 Participants10 Participants5 Participants
Sex: Female, Male
Female
2 Participants3 Participants1 Participants
Sex: Female, Male
Male
6 Participants12 Participants6 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 80 / 8
serious
Total, serious adverse events
0 / 80 / 8

Outcome results

Primary

DOCS Neurobehavioral Measure (DOCS = Disorders of Consciousness Scale) Change

The primary outcome, the DOCS, is a reliable, valid and precise measure of global neurobehavioral functioning shown to remain stable over six weeks.The DOCS-25 starts with a systematic observation followed by administration of 25 sensory stimuli. Best responses to each stimulus are rated on a scale of 0 to 2 and total raw scores range from 0 (worst) to 50 (best). The DOCS change was calculated as the value at endpoint (6 weeks after Baseline) minus the value at Baseline.

Time frame: Baseline and immediately after treatment ends (6 weeks after Baseline)

ArmMeasureValue (MEAN)Dispersion
FASTDOCS Neurobehavioral Measure (DOCS = Disorders of Consciousness Scale) Change13.5 units on a scaleStandard Deviation 8.2
ShamDOCS Neurobehavioral Measure (DOCS = Disorders of Consciousness Scale) Change18.9 units on a scaleStandard Deviation 15.6
Comparison: The planned sample of 15 per group provided 80% power for a one-sided t-test to detect be-tween group endpoint differences in DOCS averages equivalent to an effect size of .91 (9 units). Clinically, this assumes that the FAST protocol would facilitate progression from one clinical state to another (e.g., vegetative (VS) to minimally conscious (MCS) states). The hypothesized effect was based on average DOCS change for a severe TBI sample receiving three weeks of acute rehabilitation.p-value: 0.46595% CI: [-11.1, 21.9]t-test, 1 sided
Secondary

Coma Near Coma Scale

The CNC scale measures arousal and awareness and test stimuli are administered to elicit a specified behavior. Presence/absence of this behavior is scored as 0, 2 or 4. Total raw scores range from 0 (consistently responsive) to 36 (extreme coma). The CNC change score was calculated as the 8th CNC measure minus the Baseline CNC measure. Since 2 CNC measurements were collected per week, the 8th CNC measure occurred in Week 4. To calculate the change, we used the eighth CNC measure because two patients (one per group) recovered full consciousness after the eighth CNC measure. In the second statistical analysis, all CNC measures were used to calculate the slope; this includes the Baseline CNC and CNC measures 2-8. Again, we used the first 8 CNC measures (instead of all 12 collected over 6 weeks of treatment) because two patients recovered full consciousness after the eighth CNC measure.

Time frame: Baseline and after the 8th CNC assessment (4 weeks after Baseline)

ArmMeasureValue (MEAN)Dispersion
FASTComa Near Coma Scale1.0 units on a scaleStandard Deviation 0.6
ShamComa Near Coma Scale0.25 units on a scaleStandard Deviation 0.7
Comparison: Power was not calculated for the CNC because the effect size was not published.p-value: 0.04995% CI: [-1.51, -0.00493]t-test, 1 sided
p-value: 0.0022t-test, 1 sided

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026